Literature DB >> 8870569

Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients.

S Basu1, R Senior, C Dore, A Lahiri.   

Abstract

OBJECTIVE: To determine the prognostic role of thallium-201 imaging compared with that of exercise electrocardiography in patients with acute myocardial infarction treated by thrombolysis.
DESIGN: Patients who remained free of adverse cardiac events six weeks after myocardial infarction had stress and rest 201TI imaging and exercise electrocardiography and were followed up for 8-32 months. Adverse cardiac events (death, reinfarction, unstable angina, and congestive heart failure) were documented.
SETTING: Large district general hospital, Middlesex.
SUBJECTS: 100 consecutive male and female patients who were stable six weeks after thrombolysis for myocardial infarction. MAIN OUTCOME MEASURES: Prediction of occurrence of adverse cardiac events after myocardial infarction by exercise cardiography and 201TI myocardial perfusion imaging.
RESULTS: Reversible ischaemia on 201TI imaging predicted adverse cardiac events in 33 out of 37 patients with such events during follow up (hazard ratio 8.1 (95% confidence interval 2.7 to 23.8), P < 0.001). Exercise electrocardiography showed reversible ischaemia in 33 patients, of whom 13 had subsequent events, and failed to predict events in 24 patients (hazard ratio 1.1 (0.56 to 2.2), P = 0.8).
CONCLUSION: 201TI imaging is a sensitive predictor of subsequent adverse cardiac events in patients who have received thrombolysis after acute myocardial infarction, whereas exercise electrocardiography fails to predict outcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870569      PMCID: PMC2359060          DOI: 10.1136/bmj.313.7061.844

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

1.  Comparison of early exercise treadmill test and oral dipyridamole thallium-201 tomography for the identification of jeopardized myocardium in patients receiving thrombolytic therapy for acute Q-wave myocardial infarction.

Authors:  A Jain; R R Hicks; D M Frantz; G H Myers; M W Rowe
Journal:  Am J Cardiol       Date:  1990-09-01       Impact factor: 2.778

2.  Coronary prognostic index for predicting survival after recovery from acute myocardial infarction.

Authors:  R M Norris; D E Caughey; L W Deeming; C J Mercer; P J Scott
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

3.  Technetium 99m-labeled sestamibi imaging reliably identifies retained contractile reserve in dyssynergic myocardial segments.

Authors:  R Senior; U Raval; A Lahiri
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

Review 4.  Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells.

Authors:  R Rossaint; U Pison; H Gerlach; K J Falke
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

5.  Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction.

Authors:  J A Leppo; J O'Brien; J A Rothendler; J D Getchell; V W Lee
Journal:  N Engl J Med       Date:  1984-04-19       Impact factor: 91.245

6.  Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events.

Authors:  K A Brown; J O'Meara; C E Chambers; D A Plante
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

7.  Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography.

Authors:  R S Gibson; D D Watson; G B Craddock; R S Crampton; D L Kaiser; M J Denny; G A Beller
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

8.  Prognostic value of exercise testing soon after myocardial infarction.

Authors:  P Théroux; D D Waters; C Halphen; J C Debaisieux; H F Mizgala
Journal:  N Engl J Med       Date:  1979-08-16       Impact factor: 91.245

9.  Predicting the extent and location of coronary artery disease during the early postinfarction period by quantitative thallium-201 scintigraphy.

Authors:  R S Gibson; G J Taylor; D D Watson; P T Stebbins; R P Martin; R S Crampton; G A Beller
Journal:  Am J Cardiol       Date:  1981-05       Impact factor: 2.778

10.  Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularisation in severe ischaemic left ventricular dysfunction.

Authors:  R Senior; B Glenville; S Basu; B S Sridhara; E Anagnostou; R Stanbridge; S J Edmondson; C E Handler; E B Raftery; A Lahiri
Journal:  Br Heart J       Date:  1995-10
View more
  8 in total

1.  The role of cardiac imaging in optimizing therapy in heart failure.

Authors:  A Lahiri
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 3.  Role of nuclear imaging after coronary revascularization.

Authors:  George L Adams; Srivani R Ambati; John M Adams; Salvador Borges-Neto
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

4.  The VANQWISH Trial: support for the noninvasive strategy for risk stratification after acute myocardial infarction.

Authors:  G A Beller; K A Brown
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

5.  Risk stratifying patients who survive an acute myocardial infarction.

Authors:  M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

6.  Myocardial viability assessed by dobutamine stress echocardiography predicts reduced mortality early after acute myocardial infarction: determining the risk of events after myocardial infarction (DREAM) study.

Authors:  J M A Swinburn; R Senior
Journal:  Heart       Date:  2005-04-14       Impact factor: 5.994

7.  Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction.

Authors:  V Chiamvimonvat; S G Goodman; A Langer; A Barr; M R Freeman
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

8.  Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome.

Authors:  K M J Douglas; A V Pace; G J Treharne; A Saratzis; P Nightingale; N Erb; M J Banks; G D Kitas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.